- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Dupilumab – July 2018
Dupilumab: Injection 300 mg in 2 mL single dose pre-filled syringe; Dupixent®
Last updated
9 November 2018